Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ARRY [NASD]
Array BioPharma, Inc.
Index- P/E- EPS (ttm)-0.62 Insider Own5.84% Shs Outstand125.98M Perf Week-2.96%
Market Cap495.10M Forward P/E- EPS next Y-0.65 Insider Trans-6.29% Shs Float119.95M Perf Month-10.48%
Income-74.70M PEG- EPS next Q-0.23 Inst Own97.10% Short Float14.31% Perf Quarter3.97%
Sales61.50M P/S8.05 EPS this Y-72.70% Inst Trans5.43% Short Ratio10.37 Perf Half Y-28.55%
Book/sh-0.19 P/B- EPS next Y5.80% ROA-52.40% Target Price7.57 Perf Year-29.32%
Cash/sh0.87 P/C4.51 EPS next 5Y10.00% ROE468.30% 52W Range3.39 - 7.10 Perf YTD-21.56%
Dividend- P/FCF- EPS past 5Y22.50% ROI-65.80% 52W High-34.65% Beta1.91
Dividend %- Quick Ratio2.60 Sales past 5Y19.30% Gross Margin32.50% 52W Low36.87% ATR0.20
Employees265 Current Ratio2.60 Sales Q/Q-22.00% Oper. Margin-87.00% RSI (14)63.42 Volatility6.18% 5.11%
OptionableYes Debt/Eq- EPS Q/Q-5.30% Profit Margin- Rel Volume8.42 Prev Close3.93
ShortableYes LT Debt/Eq- EarningsAug 12 BMO Payout- Avg Volume1.65M Price4.64
Recom1.60 SMA2010.46% SMA5010.37% SMA200-3.17% Volume5,617,569 Change18.07%
09-Aug-13Reiterated Stifel Buy $7 → $8
23-Jul-10Upgrade UBS Neutral → Buy $4.25
22-Apr-10Downgrade UBS Buy → Neutral
05-Nov-09Upgrade UBS Neutral → Buy
08-Sep-09Downgrade UBS Buy → Neutral
04-Sep-09Downgrade Robert W. Baird Outperform → Neutral $10 → $3
04-Sep-09Downgrade Leerink Swann Outperform → Mkt Perform $6 → $2
04-Sep-09Downgrade Boenning & Scattergood Outperform → Neutral
17-Jun-09Initiated Boenning & Scattergood Outperform $6
07-May-08Reiterated Rodman & Renshaw Mkt Outperform $18 → $15
07-Feb-08Initiated William Blair Outperform
20-Dec-07Reiterated Collins Stewart Buy $17 → $16
04-Dec-07Initiated Morgan Joseph Buy $16
07-Nov-07Reiterated Collins Stewart Buy $20 → $17
09-Oct-07Initiated Lehman Brothers Overweight $16
13-Aug-07Initiated Rodman & Renshaw Mkt Outperform $18
23-May-07Initiated JP Morgan Overweight
04-Jan-07Reiterated Piper Jaffray Outperform $14 → $20
12-Jun-14 10:58AM  3 Reasons to Watch Array Biopharma Inc. at Motley Fool
10:58AM  3 Reasons to Watch Array Biopharma Inc.
11-Jun-14 02:00PM  Array BioPharma To Present At The Wells Fargo Securities 2014 Healthcare Conference PR Newswire
02:00PM  Array BioPharma To Present At The Wells Fargo Securities 2014 Healthcare Conference
02-Jun-14 03:49PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
03:49PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
01:02PM  Array BioPharma receives orphan status for kinase inhibitor at theflyonthewall.com
01:02PM  Array BioPharma receives orphan status for kinase inhibitor
01:00PM  Two Array-Invented MEK Inhibitors Showcased At ASCO PR Newswire
01:00PM  Two Array-Invented MEK Inhibitors Showcased At ASCO
31-May-14 09:20AM  Eight Analyst Stocks to Buy Under $10 for Big Upside 24/7 Wall St.
09:20AM  Eight Analyst Stocks to Buy Under $10 for Big Upside
30-May-14 08:20AM  The Zacks Analyst Blog Highlights: Facebook, AT&T, Array BioPharma, Biogen Idec and Celgene Zacks
08:20AM  The Zacks Analyst Blog Highlights: Facebook, AT&T, Array BioPharma, Biogen Idec and Celgene
29-May-14 04:10PM  Array BioPharma Collaborates with Biogen Zacks
04:10PM  Array BioPharma Collaborates with Biogen
28-May-14 09:14AM  Array and BioPharma Biogen to collaborate in inhibitor discovery and development at theflyonthewall.com
09:14AM  Array and BioPharma Biogen to collaborate in inhibitor discovery and development
09:10AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
09:10AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
09:00AM  Array BioPharma Announces Drug Discovery Collaboration Agreement With Biogen Idec PR Newswire
27-May-14 05:30PM  Array BioPharma To Present At The Jefferies 2014 Global Healthcare Conference PR Newswire
20-May-14 12:04PM  Array BioPharma (ARRY) Presents at UBS Global Healthcare Conference (Transcript) at Seeking Alpha
19-May-14 04:07PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
03:03PM  Array BioPharma hires new Chief Scientific Officer, VP of R&D at theflyonthewall.com
03:00PM  Array BioPharma Announces Key Additions To Scientific Leadership PR Newswire
16-May-14 01:04PM  ARRAY BIOPHARMA INC Financials EDGAR Online Financials
14-May-14 07:20PM  Array Biopharma's (ARRY) CEO Ron Squarer Presents at Bank of America Merrill Lynch Health Care Conference (Transcript) at Seeking Alpha
08:00AM  Array BioPharma Announces Clinical Data Presentations At The 2014 ASCO Annual Meeting PR Newswire
12-May-14 12:00PM  Array BioPharma To Present At The Bank of America Merrill Lynch Healthcare Conference and the UBS Global Healthcare Conference PR Newswire +6.60%
09-May-14 11:02AM  Array BioPharma receives orphan status for multiple myeloma treatment at theflyonthewall.com +7.95%
06:02AM  ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report EDGAR Online
29-Apr-14 03:01PM  U.S./Canada daily earnings hits & misses April 29 - 1500 ET Reuters +7.12%
12:28PM  Array BioPharma's CEO Discusses F3Q 2014 Results - Earnings Call Transcript at Seeking Alpha
12:02PM  U.S./Canada daily earnings hits & misses April 29 - 1200 ET Reuters
09:00AM  Array BioPharma Inc. Earnings Call scheduled for 9:00 am ET today CCBN
08:49AM  Array BioPharma Inc. Earnings Call scheduled for 9:00 am ET today CCBN
08:02AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib EDGAR Online
08:00AM  Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2014 PR Newswire
07:07AM  Q3 2014 Array BioPharma Inc. Earnings Release - Before Market Open CCBN
28-Apr-14 04:01PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:00PM  Charles M. Baum, M.D., PH.D. Joins Array BioPharma Board Of Directors PR Newswire
23-Apr-14 06:30PM  Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2014 On April 29, 2014 PR Newswire
02:28PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
01:22PM  Binimetinib Continues To Advance In Clinical Development PR Newswire
27-Mar-14 02:20PM  Array BioPharma: A Biotech With Many Shots On Goal at Seeking Alpha
05-Mar-14 01:13PM  Price Movements, Clinical Trial Results, and Solid Financial Reports - Analyst Notes on Pfizer, Dendreon, DepoMed, Globus Medical, and Array PR Newswire
03-Mar-14 08:39AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:00AM  Array BioPharma Provides Clinical Update On ARRY-502 For Asthma At Scientific Meeting PR Newswire
26-Feb-14 04:26PM  [video] Array CEO: Partnerships Smart While Cancer Drug Develops at TheStreet
04:26PM  [video] Array CEO: Partnerships Smart While Cancer Drug Develops
20-Feb-14 11:30AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
18-Feb-14 12:45PM  Array BioPharma To Present At The RBC Capital Markets Global Healthcare And Cowen Annual Healthcare Conferences PR Newswire
11-Feb-14 01:04PM  ARRAY BIOPHARMA INC Financials EDGAR Online Financials
07-Feb-14 08:15AM  Eight Biotech Stocks Trading Near $5 With Huge Upside Potential at 24/7 Wall St.
08:15AM  Eight Biotech Stocks Trading Near $5 With Huge Upside Potential
06-Feb-14 04:30PM  Array BioPharma To Present At The Leerink Swann Global Healthcare Conference PR Newswire
05-Feb-14 04:56PM  ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report EDGAR Online
04-Feb-14 04:03PM  Array BioPharma's CEO Discusses F2Q14 Results - Earnings Call Transcript at Seeking Alpha
04:03PM  Array BioPharma's CEO Discusses F2Q14 Results - Earnings Call Transcript
12:43PM  Why Array Biopharma Inc. Shares (Briefly) Popped at Motley Fool
09:00AM  Array BioPharma Inc. Earnings Call scheduled for 9:00 am ET today CCBN
08:49AM  Array BioPharma Inc. Earnings Call scheduled for 9:00 am ET today CCBN
08:07AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statem EDGAR Online
08:00AM  Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2014 PR Newswire
07:34AM  Array BioPharma Inc. Earnings Call scheduled for 9:00 am ET today CCBN
03-Feb-14 10:43AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online -6.03%
07:07AM  Q2 2014 Array BioPharma Inc. Earnings Release - After Market Close CCBN
07:07AM  Q2 2014 Array BioPharma Inc. Earnings Release - After Market Close
29-Jan-14 11:00AM  Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2014 on February 4, 2014 PR Newswire -5.74%
11:00AM  Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2014 on February 4, 2014
15-Jan-14 01:09PM  Array BioPharma's CEO Presents at JPMorgan Healthcare Conference (Transcript) at Seeking Alpha
01:09PM  Array BioPharma's CEO Presents at JPMorgan Healthcare Conference (Transcript)
03-Jan-14 01:30PM  Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference PR Newswire
01:30PM  Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference
31-Dec-13 04:18PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
04:18PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement
27-Dec-13 04:04PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:04PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers
14-Dec-13 08:15AM  3 Horrendous Health-Care Stocks This Week at Motley Fool
08:15AM  3 Horrendous Health-Care Stocks This Week
12-Dec-13 03:16AM  Array gets a big vote of confidence optionMONSTER
03:16AM  Array gets a big vote of confidence
11-Dec-13 06:22PM  Nasdaq stocks posting largest percentage decreases AP
01:30PM  Nasdaq stocks posting largest percentage decreases AP
10-Dec-13 05:59PM  Nasdaq stocks posting largest percentage decreases AP
01:56PM  Nasdaq stocks posting largest percentage decreases AP
09-Dec-13 08:32PM  Why Array BioPharma, Genie Energy, and Hanwha SolarOne Tumbled Today at Motley Fool -12.54%
08:32PM  Why Array BioPharma, Genie Energy, and Hanwha SolarOne Tumbled Today
06:03PM  Nasdaq stocks posting largest percentage decreases AP
01:33PM  Nasdaq stocks posting largest percentage decreases AP
12:06PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
12:06PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
12:04PM  Array says ARRY-614 data shows pronounced platelet effect in some patients theflyonthewall.com
12:04PM  Array says ARRY-614 data shows pronounced platelet effect in some patients
12:00PM  Array BioPharma Provides Clinical Update On ARRY-614 For Myelodysplastic Syndromes At The 2013 American Society Of Hematology Meeting PR Newswire
12:00PM  Array BioPharma Provides Clinical Update On ARRY-614 For Myelodysplastic Syndromes At The 2013 American Society Of Hematology Meeting
08:30AM  Array BioPharma Provides Clinical Update On Filanesib (ARRY-520) For Multiple Myeloma At The 2013 American Society of Hematology Meeting PR Newswire
08:30AM  Array BioPharma Provides Clinical Update On Filanesib (ARRY-520) For Multiple Myeloma At The 2013 American Society of Hematology Meeting
03-Dec-13 09:31PM  Array BioPharma's CEO Presents at Piper Jaffray Healthcare Conference (Transcript) at Seeking Alpha
Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases primarily in North America, Europe, and the Asia Pacific. Its proprietary clinical programs include ARRY-520, a kinesin spindle protein inhibitor, which is in Phase 2 clinical trial for patients with multiple myeloma; ARRY-614, a p38/Tie2 dual inhibitor that is in Phase 1 clinical trial for the treatment of myelodysplastic syndromes; ARRY-797, a p38 inhibitor, which is in Phase 2 clinical trial for pain; and ARRY-502, a CRTh2 antagonist that is in Phase 2 clinical trial for asthma. The company's partnered clinical programs comprise drug candidates for the treatment of cancer, including MEK162, an MEK inhibitor in Phase 3 clinical trial; Selumetinib, an MEK inhibitor in Phase 2/pivotal clinical trial; and GDC-0068 AKT inhibitor, LY2606368 Chk-1 inhibitor, and VTX-2337 toll-like receptor in Phase 2 clinical trial. Its partnered clinical programs also include Danoprevir, a Hepatitis C virus protease inhibitor in Phase 2 clinical trial; ARRY-543/ASLAN001, a HER2/EGFR inhibitor for gastric cancer in Phase 2 clinical trial; GDC-0575 and GDC-0425 Chk-1 inhibitors for cancer in Phase 1b clinical trial; ARRY-380, an HER2 inhibitor in Phase 1 clinical trial for breast cancer; and GDC-0994 in a Phase 1 dose-escalation study in patients with locally advanced or metastatic solid tumors. The company has collaborations with Amgen Inc.; ASLAN Pharmaceuticals Pte Ltd.; AstraZeneca, PLC; Celgene Corporation; Eli Lilly and Company; Genentech Inc.; Novartis International Pharmaceutical Ltd.; Oncothyreon Inc.; VentiRx Pharmaceuticals, Inc. for the development and commercialization of the partnered drugs; and Biogen Idec for the discovery and development of inhibitors to treat autoimmune disorders. Array BioPharma Inc. was founded in 1998 and is headquartered in Boulder, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MOORE JOHN RVP, General CounselNov 29Sale5.7911,66667,54620Dec 03 04:34 PM
MOORE JOHN RVP, General CounselNov 13Sale5.792001,15811,686Nov 15 05:22 PM
Ratcliffe LiamDirectorSep 27Sale5.99863,5215,170,7640Sep 30 05:46 PM
Ratcliffe LiamDirectorSep 26Sale6.02262,2071,578,958863,521Sep 30 05:46 PM
Ratcliffe LiamDirectorSep 16Sale6.14319,0331,957,6501,125,728Sep 16 05:48 PM
Ratcliffe LiamDirectorSep 13Sale6.01546,6603,287,6681,444,761Sep 16 05:48 PM
Ratcliffe LiamDirectorSep 12Sale6.10807,4794,923,1191,991,421Sep 16 05:48 PM
Ratcliffe LiamDirectorSep 06Sale5.68139,572793,2022,798,900Sep 06 05:10 PM
Ratcliffe LiamDirectorSep 05Sale5.77201,5981,163,5232,938,472Sep 06 05:10 PM
Ratcliffe LiamDirectorSep 04Sale5.87236,1161,385,6233,140,070Sep 06 05:10 PM
MOORE JOHN RVP, General CounselAug 02Option Exercise3.0443,884133,59155,770Aug 02 06:24 PM
MOORE JOHN RVP, General CounselAug 02Sale7.0343,884308,46911,886Aug 02 06:24 PM
MOORE JOHN RVP, General CounselAug 01Option Exercise2.8826,74177,11543,386Aug 02 06:24 PM
MOORE JOHN RVP, General CounselAug 01Sale7.0031,500220,63511,886Aug 02 06:24 PM
MOORE JOHN RVP, General CounselJul 25Option Exercise3.754,75917,84616,645Jul 25 07:42 PM
SNITMAN DAVIDCOO and VP, Business Devel.Jul 24Option Exercise3.7521,35780,0891,517,509Jul 25 07:49 PM
KOCH KEVINPresident, CSOJul 24Option Exercise3.7522,28683,573797,240Jul 25 07:47 PM
CARRUTHERS MICHAELCFOJul 24Option Exercise3.7515,32157,454123,134Jul 25 07:45 PM